Enlivex Therapeutics Ltd. buy melinda
Start price
26.09.17
/
50%
€14.65
Target price
28.09.17
€18.04
Performance (%)
13.71%
End price
28.09.17
€16.66
Summary
This prediction ended on 28.09.17 with a price of €16.66. The BUY prediction by melinda finished with a performance of 13.71%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Enlivex Therapeutics Ltd. | 12.500% | 12.500% | -47.266% | -82.692% |
iShares Core DAX® | -2.926% | -3.811% | 9.621% | 12.399% |
iShares Nasdaq 100 | 4.462% | 7.635% | 33.690% | 60.293% |
iShares Nikkei 225® | 0.306% | -0.065% | 4.201% | 4.153% |
iShares S&P 500 | 2.488% | 4.185% | 27.301% | 50.529% |
Comments by melinda for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Phase LE2 / 02/2017
zu folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€21.20
25.10.17
25.10.17
€22.40
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€19.12
25.10.17
25.10.17
€20.20
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.24
26.09.17
26.09.17
€20.00
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€47.63
27.01.17
27.01.17
€72.16
27.07.17
27.07.17
-53.77%
27.07.17
27.07.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€185.81
14.10.15
14.10.15
€234.52
14.04.16
14.04.16
-54.95%
14.04.16
14.04.16